Home/Tag: disorders

Alzheimer’s researchers receive Chan Zuckerberg Initiative funding

A team of researchers at Washington University School of Medicine in St. Louis has been funded by the Chan Zuckerberg Initiative (CZI)to study the root causes of neurodegenerative disorders. The project at the School of Medicine will analyze genes that may help protect some patients from Alzheimer’s disease. The researchers suspect that certain variants in TREM2 and another

Drug compound shows promise against rheumatoid arthritis

Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis. The new inhibitor is more selective than other compounds designed to target the same inflammatory pathway, according to new research from Washington University School of Medicine in St. Louis. Such precision, along with

Predicting Autism & Other Developmental Delays: How Tech Can Empower Doctors

The current system by which we typically diagnose developmental and behavioral disorders in children is dysfunctional, as specialists are vastly outnumbered by at risk-children in need of appointments. For delays like autism, the earlier the diagnosis, the earlier the intervention can start and the more effective it becomes. We are in the early stages of

December 20th, 2017|Categories: Autism, Disease Specific|Tags: , , , |

Technology Key to Fighting Neurological Disease

New technologies may be on the way to better help doctors diagnose and treat patients with neurological diseases. Researchers from the National Neuroscience Institute (NNI) and Nanyang Technological University, Singapore (NTU) have come together to develop several new technologies, including an artificial intelligence system that can accurately identify types of traumatic brain injuries from computed

September 3rd, 2017|Categories: General News|Tags: , , , |

Genome Therapy Could Lead to New Treatment for Life-threatening Blood Disorders

by University of New South Wales   Genome therapy with beneficial natural mutation could lead to new treatment for life-threatening blood disorders By introducing a beneficial natural mutation into blood cells using the gene-editing technique CRISPR, a UNSW Sydney-led team of scientists has been able to switch on production of foetal haemoglobin - an advance